Identification of Released Bacterial Extracellular Vesicles Containing Lpp20 from <i>Helicobacter pylori</i>
<i>Helicobacter pylori</i> is a pathogenic bacterium that causes gastric and extragastric diseases. We have previously demonstrated that one of the mechanisms of <i>H. pylori</i>-associated chronic immune thrombocytopenia involves immune complexes of platelets, a <i>H....
Saved in:
| Main Authors: | Aoi Okamoto, Tatsuki Shibuta, Nanaka Morita, Ryota Fujinuma, Masaya Shiraishi, Reimi Matsuda, Mayu Okada, Satoe Watanabe, Tsukuru Umemura, Hiroaki Takeuchi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/13/4/753 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01) -
<i>Helicobacter pylori</i> Vaccine: Mechanism of Pathogenesis, Immune Evasion and Analysis of Vaccine Types
by: Jingwen Gong, et al.
Published: (2025-05-01) -
Cytoprotection of the Gastric Mucosa and Eradication Therapy of <i>Helicobacter Pylori</i> Infection: Points of Conjugation
by: A. S. Trukhmanov, et al.
Published: (2025-06-01) -
Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw, Poland
by: Tadeusz Tacikowski, et al.
Published: (2017-05-01) -
Challenges and Prospects for Eradication of <i>Helicobacter pylori</i>: Targeting Virulence Factors, Metabolism, and Vaccine Innovation
by: Adrian Bakiera, et al.
Published: (2025-06-01)